Author

Emmalyn Lecky

Beth Israel Deaconess Medical CenterORCID 0000-0001-6005-1895Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Alex TokeriD· 1 shared Alissandra L. HillisiD· 1 shared David A. FrumaniD· 1 shared David E. RootiD· 1 shared Haley E. ManchesteriD· 1 shared Jenny HögströmiD· 1 shared John G. ClohessyiD· 1 shared Jonah LeeiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex TokerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedJul 18, 2024

Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer

Alissandra L. Hillis, Timothy D. Martin, Haley E. Manchester…·Alex Toker

This study identifies a synergistic effect between AKT inhibitors and pitavastatin in killing triple-negative breast cancer cells by targeting cholesterol trafficking.

47 citationstop 2%

humangenetic perturbation / CRISPR

𝕏 PostBluesky